Cytokine Polymorphisms, Their Influence and Levels in Brazilian Patients with Pulmonary Tuberculosis during Antituberculosis Treatment
Figure 8
Influence of IFNG +874T/A gene SNP on IFN-γ plasma levels (a) and mRNA expression (b), IFNG +2109A/G gene SNP on IFN-γ plasma levels (c), TNF −308G/C gene SNP on TNF-α plasma levels (d), and TGFB1 +29C/T gene SNP on TGF-β plasma levels (e) in PTB patients that have all three time points of the treatment: T1 (after diagnosis and first month), T2 (three months), and T3 (six months). Data are shown as median levels. *.
